Global versus organ-specific outcome measures in systemic lupus erythematosus: comment on the articles by Furie et al, Nikpour et al, Wallace et al, Burgos et al, and Ramos-Casals et al

被引:2
作者
Monach, Paul A. [1 ]
机构
[1] Boston Univ, Sch Med, Boston, MA 02118 USA
关键词
DISEASE; RITUXIMAB; FLARE;
D O I
10.1002/acr.20053
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:580 / 581
页数:2
相关论文
共 8 条
  • [1] Disease Activity and Damage Are Not Associated With Increased Levels of Fatigue in Systemic Lupus Erythematosus Patients From a Multiethnic Cohort: LXVII
    Burgos, Paula I.
    Alarcon, Graciela S.
    McGwin, Gerald, Jr.
    Crews, Kendra Q.
    Reveille, John D.
    Vila, Luis M.
    [J]. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2009, 61 (09): : 1179 - 1186
  • [2] AMERICAN-COLLEGE-OF-RHEUMATOLOGY PRELIMINARY DEFINITION OF IMPROVEMENT IN RHEUMATOID-ARTHRITIS
    FELSON, DT
    ANDERSON, JJ
    BOERS, M
    BOMBARDIER, C
    FURST, D
    GOLDSMITH, C
    KATZ, LM
    LIGHTFOOT, R
    PAULUS, H
    STRAND, V
    TUGWELL, P
    WEINBLATT, M
    WILLIAMS, HJ
    WOLFE, F
    KIESZAK, S
    [J]. ARTHRITIS AND RHEUMATISM, 1995, 38 (06): : 727 - 735
  • [3] Novel Evidence-Based Systemic Lupus Erythematosus Responder Index
    Furie, Richard A.
    Petri, Michelle A.
    Wallace, Daniel J.
    Ginzler, Ellen M.
    Merrill, Joan T.
    Stohl, William
    Chatham, W. Winn
    Strand, Vibeke
    Weinstein, Arthur
    Chevrier, Marc R.
    Zhong, Z. John
    Freimuth, William W.
    [J]. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2009, 61 (09): : 1143 - 1151
  • [4] Frequency and Determinants of Flare and Persistently Active Disease in Systemic Lupus Erythematosus
    Nikpour, Mandana
    Urowitz, Murray B.
    Ibanez, Dominique
    Gladman, Dafna D.
    [J]. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2009, 61 (09): : 1152 - 1158
  • [5] Rituximab in systemic lupus erythematosus A systematic review of off-label use in 188 cases
    Ramos-Casals, M.
    Soto, M. J.
    Cuadrado, M. J.
    Khamashta, M. A.
    [J]. LUPUS, 2009, 18 (09) : 767 - 776
  • [6] Rituximab and lupus: good in real life, bad in controlled trials. Comment on the article by Lu et al
    Ramos-Casals, Manuel
    Diaz-Lagares, Candido
    Khamashta, Munther A.
    [J]. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2009, 61 (09): : 1281 - 1282
  • [7] A Phase II, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Belimumab in Patients With Active Systemic Lupus Erythematosus
    Wallace, Daniel J.
    Stohl, William
    Furie, Richard A.
    Lisse, Jeffrey R.
    McKay, James D.
    Merrill, Joan T.
    Petri, Michelle A.
    Ginzler, Ellen M.
    Chatham, W. Winn
    McCune, W. Joseph
    Fernandez, Vivian
    Chevrier, Marc R.
    Zhong, Z. John
    Freimuth, William W.
    [J]. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2009, 61 (09): : 1168 - 1178
  • [8] The Impact of Flare on Disease Costs of Patients With Systemic Lupus Erythematosus
    Zhu, Tracy Y.
    Tam, Lai-Shan
    Lee, Vivian W. -Y.
    Lee, Kenneth K. -C.
    Li, Edmund K.
    [J]. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2009, 61 (09): : 1159 - 1167